NanoRepro AG/€NN6
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About NanoRepro AG
NanoRepro AG is a German company operating in the healthcare industry, specializing in the development and distribution of diagnostic rapid tests. The company offers a range of products primarily focused on fertility, infectious diseases, and preventive care, providing over-the-counter solutions that cater to both professional and consumer markets. Founded in 2002, NanoRepro is headquartered in Marburg, Germany. The company leverages a network of distribution partners to enhance its market presence across various countries, reflecting a strategic focus on expanding its geographical footprint. NanoRepro's competitive strength lies in its emphasis on research and development, supporting its capability to introduce innovative diagnostic solutions.
Ticker
€NN6
Sector
Primary listing
XETRA
Employees
21
Headquarters
Website
NanoRepro AG Metrics
BasicAdvanced
€25m
-
-€0.14
0.66
-
Price and volume
Market cap
€25m
Beta
0.66
52-week high
€2.27
52-week low
€1.33
Average daily volume
18k
Financial strength
Current ratio
31.902
Quick ratio
24.557
Profitability
EBITDA (TTM)
-2.268
Gross margin (TTM)
58.90%
Net profit margin (TTM)
-33.37%
Operating margin (TTM)
-44.60%
Effective tax rate (TTM)
-0.66%
Revenue per employee (TTM)
€250,000
Management effectiveness
Return on assets (TTM)
-3.70%
Return on equity (TTM)
-4.52%
Valuation
Price to revenue (TTM)
4.865
Price to book
0.68
Price to tangible book (TTM)
0.74
Growth
Revenue change (TTM)
45.00%
Earnings per share change (TTM)
-46.12%
3-year revenue growth (CAGR)
-57.80%
10-year revenue growth (CAGR)
19.02%
3-year earnings per share growth (CAGR)
-23.96%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs